The impact of type 2 inflammation and barrier dysfunction in the pathogenesis of chronic disease in atopic dermatitis.
In this short video, Prof. Elaine Siegfried summarizes the effect that barrier dysfunction has in reducing the defenses of the skin to external factors, and how type 2 cytokines can be released in response to barrier breach or underlying inflammation to propagate chronic disease in AD.
Professor of Pediatrics and Dermatology in the Department of Pediatrics, Division of Dermatology at Saint Louis University School of Medicine, US
See author’s profile